Cannabinoid-2 receptor limits inflammation, oxidative/nitrosative stress, and cell death in nephropathy.
Cannabinoid-2 receptor limits inflammation, oxidative/nitrosative stress, and cell death in nephropathy.
复制标题
DOI:
10.1016/j.freeradbiomed.2009.11.022
复制
发表时间:
2010-02-01
影响因子:
7.4
通讯作者:
Pacher, Pal
中科院分区:
文献类型:
--
作者:
Mukhopadhyay, Partha;Rajesh, Mohanraj;Pan, Hao;Patel, Vivek;Mukhopadhyay, Bani;Batkai, Sandor;Gao, Bin;Hasko, Gyoergy;Pacher, Pal
Cisplatin is an important chemotherapeutic agent available; however the nephrotoxicity is limiting its clinical use. Enhanced inflammatory response and oxidative/nitrosative stress appear to play a key role in the development of cisplatin-induced nephropathy. Activation of cannabinoid-2 (CB2) receptors with selective agonists exerts anti-inflammatory and tissue protective effects in various disease models. We have investigated the role of CB2 receptors in cisplatin-induced nephrotoxicity using selective CB2 receptor agonist HU-308 and CB2 knockout mice. Cisplatin significantly increased inflammation (leukocyte infiltration, CXCL1/2, MCP-1, TNF-α and IL1β levels), expressions of adhesion molecule ICAM-1 and superoxide generating enzymes NOX2, NOX4 and NOX1, enhanced ROS generation, iNOS expression, nitrotyrosine formation, apoptotic and poly(ADP-ribose) polymerase-dependent cell death in the kidneys of mice, associated with marked histopathological damage and impaired renal function (elevated serum BUN and creatinine levels) 3 days following the administration of the drug. CB2 agonist attenuated the cisplatin-induced inflammatory response, oxidative/nitrosative stress and cell death in the kidney and improved renal function, while CB2 knockouts developed enhanced inflammation and tissue injury. Thus, the endocannabinoid system through CB2 receptors protects against cisplatin-induced kidney damage by attenuating inflammation and oxidative/nitrosative stress, and selective CB2 agonists may represent a promising novel approach to prevent this devastating complication of chemotherapy.
登录
查看更多内容
影响因子:
13.6
作者:
Davis, CA;Nick, HS;Agarwal, A
通讯作者:
Agarwal, A
DOI:
10.1152/ajpheart.00373.2007
发表时间:
2007-08-01
影响因子:
4.8
作者:
Batkai, Sandor;Rajesh, Mohanraj;Pacher, Pal
通讯作者:
Pacher, Pal
影响因子:
3.9
作者:
Beckman JS
通讯作者:
Beckman JS
影响因子:
4.8
作者:
Murikinati, Sasidhar;Juettler, Eric;Schwaninger, Markus
通讯作者:
Schwaninger, Markus
影响因子:
7.4
作者:
Levrand, Sandra;Vannay-Bouchiche, Christine;Liaudet, Lucas
通讯作者:
Liaudet, Lucas